Market Study on Oncology Mice Models: North America Accounts for Nearly Half Global Market Share

List of Tables

Oncology Mice Models Market - Scope of Report

The latest publication by Persistence Market Research on the oncology mice models market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for oncology mice models and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oncology mice models market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the oncology mice models market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oncology mice models market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the oncology mice models market offers information divided into three important segments - product, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Humanized Immune System Mice Models

Syngeneic Tumor Mice Models

Immunodeficient Mice Models

NOG Mice Models

Spontaneous Tumor Mice Models

Others

End User

Contract Research Organizations

Pharma and Biopharma Companies

Academic and Research Institutes

Region

North America

Latin America

Europe

Asia Pacific

Middle East and Africa (MEA)

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for oncology mice models over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis impacted market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the oncology mice models market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the oncology mice models market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the oncology mice models market more accurate and reliable

Product Code: PMRREP33046

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Oncology Drugs - Pipeline Analysis
- 4.1.1. By Intervention
- 4.1.2. By Phase
- 4.1.3. By Funding Authority
4.2. Immuno-Oncology Drugs - Pipeline Analysis
- 4.2.1. By Phase
- 4.2.2. By Funding Authority
4.3. List of Pharma Companies That Have Ongoing Immuno-Oncology Clinical Trials
4.4. List of Academic & Research Institutes Involved In Ongoing Immuno-Oncology Clinical Trials
4.5. List of Preclinical CROs
4.6. Parent Market Analysis
4.7. Relative Number of Combination Oncology Therapy Trials
4.8. Landscape of Immuno-Oncology Drug Development
4.9. List of Preclinical immuno-oncology models
- 4.9.1. Cell lines
- 4.9.2. Mice Models
- 4.9.3. Organoids/ spheroids
4.10. Key Regulatory Scenario
4.11. Porter's Analysis
4.12. PESTLE Analysis
4.13. Supply Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Covid-19 Pandemic
- 5.2.2. Prevalence of cancer
- 5.2.3. Rise in R&D investments
- 5.2.4. Stringent Regulations
- 5.2.5. Rise in number of pre-clinical and clinical studies
- 5.2.6. Increasing investment in Cancer research
- 5.2.7. GDP Growth
- 5.2.8. Advancements in Models
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.5. Recovery Scenario - Short term, Midterm, and Long Term Impact

7. Global Oncology Mice Models Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017- 2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
- 8.3.1. Humanized Immune System Mice Models
- 8.3.2. Syngeneic Tumor Mice Models
- 8.3.3. Immunodeficient Mice Models
- 8.3.4. NOG Mice Models
- 8.3.5. Spontaneous Tumor Mice Models
- 8.3.6. Others
8.4. Market Attractiveness Analysis By Product

9. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 9.3.1. Contract Research Organizations
- 9.3.2. Pharma and Biopharma Companies
- 9.3.3. Academic and Research Institutes
9.4. Market Attractiveness Analysis By Indication

10. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by Region

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 10.3.1. The North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
10.4 Market Attractiveness Analysis

11. North America Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.3.1. By Country
- 11.3.2. By Product
- 11.3.3. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis

12. Latin America Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.3.1. By Country
- 12.3.2. By Product
- 12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Europe Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.3.1. By Country
- 13.3.2. By Product
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Asia Pacific Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.3.1. By Country
- 14.3.2. By Product
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. Middle East and Africa (MEA) Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 15.3.1. By Country
- 15.3.2. By Product
- 15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. Country Level Medical Cart Market Analysis and Forecast 2022 & 2032

16.1. Introduction
- 16.1.1. Market Value Proportion Analysis
- 16.1.2. Global VS. Country Growth Comparison
16.2. U.S. Medical Cart Market Analysis
- 16.2.1. By Product
- 16.2.2. By End User
16.3. Canada Medical Cart Market Analysis
- 16.3.1. By Product
- 16.3.2. By End User
16.4. Brazil Medical Cart Market Analysis
- 16.4.1. By Product
- 16.4.2. By End User
16.5. Argentina Medical Cart Market Analysis
- 16.5.1. By Product
- 16.5.2. By End User
16.6. Mexico Medical Cart Market Analysis
- 16.6.1. By Product
- 16.6.2. By End User
16.7. Germany Medical Cart Market Analysis
- 16.7.1. By Product
- 16.7.2. By End User
16.8. Italy Medical Cart Market Analysis
- 16.8.1. By Product
- 16.8.2. By End User
16.9. France Medical Cart Market Analysis
- 16.9.1. By Product
- 16.9.2. By End User
16.10. U.K. Medical Cart Market Analysis
- 16.10.1. By Product
- 16.10.2. By End User
16.11. Spain Medical Cart Market Analysis
- 16.11.1. By Product
- 16.11.2. By End User
16.12. BENELUX Medical Cart Market Analysis
- 16.12.1. By Product
- 16.12.2. By End User
16.13. Russia Medical Cart Market Analysis
- 16.13.1. By Product
- 16.13.2. By End User
16.14. China Medical Cart Market Analysis
- 16.14.1. By Product
- 16.14.2. By End User
16.15. Japan Medical Cart Market Analysis
- 16.15.1. By Product
- 16.15.2. By End User
16.16. India Medical Cart Market Analysis
- 16.16.1. By Product
- 16.16.2. By End User
16.17. Australia and New Zealand Medical Cart Market Analysis
- 16.17.1. By Product
- 16.17.2. By End User
16.18. GCC Countries Medical Cart Market Analysis
- 16.18.1. By Product
- 16.18.2. By End User
16.19. South Africa Medical Cart Market Analysis
- 16.19.1. By Product
- 16.19.2. By End User

17. Market Structure Analysis

17.1. Market Analysis by Tier of Companies
17.2. Market Share Analysis of Top Players

18. Competition Analysis

18.1. Competition Benchmarking
18.2. Competition Dashboard
18.3. Competition Deep Dive
- 18.3.1. The Jackson Laboratory
  - 18.3.1.1. Overview
  - 18.3.1.2. Product Portfolio
  - 18.3.1.3. Key Financials
  - 18.3.1.4. SWOT Analysis
  - 18.3.1.5. Sales Footprint
  - 18.3.1.6. Strategy Overview
    - 18.3.1.6.1. Marketing Strategy
    - 18.3.1.6.2. Product Strategy
    - 18.3.1.6.3. Channel Strategy
- 18.3.2. Taconic Biosciences
  - 18.3.2.1. Overview
  - 18.3.2.2. Product Portfolio
  - 18.3.2.3. Key Financials
  - 18.3.2.4. SWOT Analysis
  - 18.3.2.5. Sales Footprint
  - 18.3.2.6. Strategy Overview
    - 18.3.2.6.1. Marketing Strategy
    - 18.3.2.6.2. Product Strategy
    - 18.3.2.6.3. Channel Strategy
- 18.3.3. Charles River Laboratories
  - 18.3.3.1. Overview
  - 18.3.3.2. Product Portfolio
  - 18.3.3.3. Key Financials
  - 18.3.3.4. SWOT Analysis
  - 18.3.3.5. Sales Footprint
  - 18.3.3.6. Strategy Overview
    - 18.3.3.6.1. Marketing Strategy
    - 18.3.3.6.2. Product Strategy
    - 18.3.3.6.3. Channel Strategy
- 18.3.4. Shanghai Model Organisms Center Inc.
  - 18.3.4.1. Overview
  - 18.3.4.2. Product Portfolio
  - 18.3.4.3. Key Financials
  - 18.3.4.4. SWOT Analysis
  - 18.3.4.5. Sales Footprint
  - 18.3.4.6. Strategy Overview
    - 18.3.4.6.1. Marketing Strategy
    - 18.3.4.6.2. Product Strategy
    - 18.3.4.6.3. Channel Strategy
- 18.3.5. Envigo
  - 18.3.5.1. Overview
  - 18.3.5.2. Product Portfolio
  - 18.3.5.3. Key Financials
  - 18.3.5.4. SWOT Analysis
  - 18.3.5.5. Sales Footprint
  - 18.3.5.6. Strategy Overview
    - 18.3.5.6.1. Marketing Strategy
    - 18.3.5.6.2. Product Strategy
    - 18.3.5.6.3. Channel Strategy
- 18.3.6. Biocytogen
  - 18.3.6.1. Overview
  - 18.3.6.2. Product Portfolio
  - 18.3.6.3. Key Financials
  - 18.3.6.4. SWOT Analysis
  - 18.3.6.5. Sales Footprint
  - 18.3.6.6. Strategy Overview
    - 18.3.6.6.1. Marketing Strategy
    - 18.3.6.6.2. Product Strategy
    - 18.3.6.6.3. Channel Strategy
- 18.3.7. Genoway
  - 18.3.7.1. Overview
  - 18.3.7.2. Product Portfolio
  - 18.3.7.3. Key Financials
  - 18.3.7.4. SWOT Analysis
  - 18.3.7.5. Sales Footprint
  - 18.3.7.6. Strategy Overview
    - 18.3.7.6.1. Marketing Strategy
    - 18.3.7.6.2. Product Strategy
    - 18.3.7.6.3. Channel Strategy
- 18.3.8. Crown Bioscience Inc. (JSR Corporation).
  - 18.3.8.1. Overview
  - 18.3.8.2. Product Portfolio
  - 18.3.8.3. Key Financials
  - 18.3.8.4. SWOT Analysis
  - 18.3.8.5. Sales Footprint
  - 18.3.8.6. Strategy Overview
    - 18.3.8.6.1. Marketing Strategy
    - 18.3.8.6.2. Product Strategy
    - 18.3.8.6.3. Channel Strategy
- 18.3.9. Cyagen
  - 18.3.9.1. Overview
  - 18.3.9.2. Product Portfolio
  - 18.3.9.3. Key Financials
  - 18.3.9.4. SWOT Analysis
  - 18.3.9.5. Sales Footprint
  - 18.3.9.6. Strategy Overview
    - 18.3.9.6.1. Marketing Strategy
    - 18.3.9.6.2. Product Strategy
    - 18.3.9.6.3. Channel Strategy
- 18.3.10. Applied stem cells
  - 18.3.10.1. Overview
  - 18.3.10.2. Product Portfolio
  - 18.3.10.3. Key Financials
  - 18.3.10.4. SWOT Analysis
  - 18.3.10.5. Sales Footprint
  - 18.3.10.6. Strategy Overview
    - 18.3.10.6.1. Marketing Strategy
    - 18.3.10.6.2. Product Strategy
    - 18.3.10.6.3. Channel Strategy
- 18.3.11. Ingenious Targeting Laboratory
  - 18.3.11.1. Overview
  - 18.3.11.2. Product Portfolio
  - 18.3.11.3. Key Financials
  - 18.3.11.4. SWOT Analysis
  - 18.3.11.5. Sales Footprint
  - 18.3.11.6. Strategy Overview
    - 18.3.11.6.1. Marketing Strategy
    - 18.3.11.6.2. Product Strategy
    - 18.3.11.6.3. Channel Strategy
- 18.3.12. PolyGene - Transgenic mice model company
  - 18.3.12.1. Overview
  - 18.3.12.2. Product Portfolio
  - 18.3.12.3. Key Financials
  - 18.3.12.4. SWOT Analysis
  - 18.3.12.5. Sales Footprint
  - 18.3.12.6. Strategy Overview
    - 18.3.12.6.1. Marketing Strategy
    - 18.3.12.6.2. Product Strategy
    - 18.3.12.6.3. Channel Strategy
- 18.3.13. Creative Biolabs
  - 18.3.13.1. Overview
  - 18.3.13.2. Product Portfolio
  - 18.3.13.3. Key Financials
  - 18.3.13.4. SWOT Analysis
  - 18.3.13.5. Sales Footprint
  - 18.3.13.6. Strategy Overview
    - 18.3.13.6.1. Marketing Strategy
    - 18.3.13.6.2. Product Strategy
    - 18.3.13.6.3. Channel Strategy
- 18.3.14. TransCure Bioservices
  - 18.3.14.1. Overview
  - 18.3.14.2. Product Portfolio
  - 18.3.14.3. Key Financials
  - 18.3.14.4. SWOT Analysis
  - 18.3.14.5. Sales Footprint
  - 18.3.14.6. Strategy Overview
    - 18.3.14.6.1. Marketing Strategy
    - 18.3.14.6.2. Product Strategy
    - 18.3.14.6.3. Channel Strategy
- 18.3.15. Champions Oncology Inc
  - 18.3.15.1. Overview
  - 18.3.15.2. Product Portfolio
  - 18.3.15.3. Key Financials
  - 18.3.15.4. SWOT Analysis
  - 18.3.15.5. Sales Footprint
  - 18.3.15.6. Strategy Overview
    - 18.3.15.6.1. Marketing Strategy
    - 18.3.15.6.2. Product Strategy
    - 18.3.15.6.3. Channel Strategy
- 18.3.16. Certis Oncology
  - 18.3.16.1. Overview
  - 18.3.16.2. Product Portfolio
  - 18.3.16.3. Key Financials
  - 18.3.16.4. SWOT Analysis
  - 18.3.16.5. Sales Footprint
  - 18.3.16.6. Strategy Overview
    - 18.3.16.6.1. Marketing Strategy
    - 18.3.16.6.2. Product Strategy
    - 18.3.16.6.3. Channel Strategy
- 18.3.17. Signature
  - 18.3.17.1. Overview
  - 18.3.17.2. Product Portfolio
  - 18.3.17.3. Key Financials
  - 18.3.17.4. SWOT Analysis
  - 18.3.17.5. Sales Footprint
  - 18.3.17.6. Strategy Overview
    - 18.3.17.6.1. Marketing Strategy
    - 18.3.17.6.2. Product Strategy
    - 18.3.17.6.3. Channel Strategy
- 18.3.18. Pharmaron
  - 18.3.18.1. Overview
  - 18.3.18.2. Product Portfolio
  - 18.3.18.3. Key Financials
  - 18.3.18.4. SWOT Analysis
  - 18.3.18.5. Sales Footprint
  - 18.3.18.6. Strategy Overview
    - 18.3.18.6.1. Marketing Strategy
    - 18.3.18.6.2. Product Strategy
    - 18.3.18.6.3. Channel Strategy
- 18.3.19. Laboratory Corporation of America Holdings
  - 18.3.19.1. Overview
  - 18.3.19.2. Product Portfolio
  - 18.3.19.3. Key Financials
  - 18.3.19.4. SWOT Analysis
  - 18.3.19.5. Sales Footprint
  - 18.3.19.6. Strategy Overview
    - 18.3.19.6.1. Marketing Strategy
    - 18.3.19.6.2. Product Strategy
    - 18.3.19.6.3. Channel Strategy
- 18.3.20. Gempharmatech
  - 18.3.20.1. Overview
  - 18.3.20.2. Product Portfolio
  - 18.3.20.3. Key Financials
  - 18.3.20.4. SWOT Analysis
  - 18.3.20.5. Sales Footprint
  - 18.3.20.6. Strategy Overview
    - 18.3.20.6.1. Marketing Strategy
    - 18.3.20.6.2. Product Strategy
    - 18.3.20.6.3. Channel Strategy
- 18.3.21. Janvier Labs
  - 18.3.21.1. Overview
  - 18.3.21.2. Product Portfolio
  - 18.3.21.3. Key Financials
  - 18.3.21.4. SWOT Analysis
  - 18.3.21.5. Sales Footprint
  - 18.3.21.6. Strategy Overview
    - 18.3.21.6.1. Marketing Strategy
    - 18.3.21.6.2. Product Strategy
    - 18.3.21.6.3. Channel Strategy
- 18.3.22. Harbour BioMed
  - 18.3.22.1. Overview
  - 18.3.22.2. Product Portfolio
  - 18.3.22.3. Key Financials
  - 18.3.22.4. SWOT Analysis
  - 18.3.22.5. Sales Footprint
  - 18.3.22.6. Strategy Overview
    - 18.3.22.6.1. Marketing Strategy
    - 18.3.22.6.2. Product Strategy
    - 18.3.22.6.3. Channel Strategy

19. Assumptions and Acronyms Used

20. Research Methodology

Product Code: PMRREP33046

List of Tables

Table 01: Global Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 02: Global Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by End User
Table 03: Global Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Region
Table 04: North America Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 05: North America Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 06: Latin America Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 07: Latin America Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 08: Europe Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 09: Europe Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 10: Asia Pacific Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 11: Asia Pacific Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 12: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, by Product
Table 13: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

List of Figures

Figure 01: Global Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 02: Global Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 03: Global Oncology Mice Models Market Absolute $ Opportunity, 2022-2032
Figure 04: Global Oncology Mice Models Market Share Analysis (%) By Product, 2022 & 2032
Figure 05: Global Oncology Mice Models Market Y-o-Y Growth (%) By Product, 2022- 2032
Figure 06: Global Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 07: Global Oncology Mice Models Market Share Analysis (%) By End User, 2022 & 2032
Figure 08: Global Oncology Mice Models Market Y-o-Y Growth (%) By End User, 2022-2032
Figure 09: Global Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 10: Global Oncology Mice Models Market Share Analysis (%) By Region, 2022 & 2032
Figure 11: Global Oncology Mice Models Market Y-o-Y Growth (%) By Region, 2022-2032
Figure 12: Global Oncology Mice Models Market Attractiveness Analysis, By Region
Figure 13: North America Oncology Mice Models Market Value (US$ Mn) Analysis, 2021 (A), 2026 (F) & 2032 (F)
Figure 14: North America Oncology Mice Models Market Value (US$ Mn) Analysis, by Product, 2022
Figure 15: North America Oncology Mice Models Market Value (US$ Mn) Analysis, by End User, 2022
Figure 16: North America Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 17: North America Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 18: North America Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 19: North America Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 20: Latin America Oncology Mice Models Market Value (US$ Mn) Analysis, 2021 (A), 2026 (F) & 2032 (F)
Figure 21: Latin America Oncology Mice Models Market Value (US$ Mn) Analysis, by Product, 2022
Figure 22: Latin America Oncology Mice Models Market Value (US$ Mn) Analysis, by End User, 2022
Figure 23: Latin America Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 24: Latin America Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 25: Latin America Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 26: Latin America Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 27: Europe Oncology Mice Models Market Value (US$ Mn) Analysis, 2021 (A), 2026 (F) & 2032 (F)
Figure 28: Europe Oncology Mice Models Market Value (US$ Mn) Analysis, by Product, 2022
Figure 29: Europe Oncology Mice Models Market Value (US$ Mn) Analysis, by End User, 2022
Figure 30: Europe Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 31: Europe Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 32: Europe Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 33: Europe Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 35: Asia Pacific Oncology Mice Models Market Value (US$ Mn) Analysis, by Product, 2022
Figure 36: Asia Pacific Oncology Mice Models Market Value (US$ Mn) Analysis, by End User, 2022
Figure 37: Asia Pacific Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 38: Asia Pacific Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 39: Asia Pacific Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 40: Asia Pacific Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 41: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$ Mn) Analysis, 2021 (A), 2026 (F) & 2032 (F)
Figure 42: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$ Mn) Analysis, by Product, 2022
Figure 43: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$ Mn) Analysis, by End User, 2022
Figure 44: Middle East and Africa (MEA) Oncology Mice Models Historical Market (US$ Mn) Analysis, 2017-2021
Figure 45: Middle East and Africa (MEA) Oncology Mice Models Market Value (US$) & Y-o-Y Growth (%), 2022-2032
Figure 46: Middle East and Africa (MEA) Oncology Mice Models Market Attractiveness Analysis, By Product
Figure 47: Middle East and Africa (MEA) Oncology Mice Models Market Attractiveness Analysis, By End User
Figure 48: U.S. Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 49: U.S. Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 50: Canada Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 51: Canada Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 52: Mexico Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 53: Mexico Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 54: Brazil Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 55: Brazil Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 56: India Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 57: India Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 58: China Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 59: China Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 60: Japan Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 61: Japan Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 62: Germany Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 63: Germany Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 64: France Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 65: France Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 66: Italy Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 67: Italy Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 68: Russia Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 69: Russia Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 70: GCC Countries Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 71: GCC Countries Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032
Figure 72: South Africa Oncology Mice Models Market Share Analysis (%) By Product, 2021 & 2032
Figure 73: South Africa Oncology Mice Models Market Share Analysis (%) By End User, 2021 & 2032

Market Study on Oncology Mice Models: North America Accounts for Nearly Half Global Market Share

Description

Table of Contents

List of Tables

Research Methodology

Table of Contents

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Market Background

6. COVID19 Crisis Analysis

7. Global Oncology Mice Models Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

8. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by Product

9. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by End User

10. Global Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032, by Region

11. North America Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

12. Latin America Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

13. Europe Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

14. Asia Pacific Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

15. Middle East and Africa (MEA) Oncology Mice Models Market Analysis 2017-2021 and Forecast 2022-2032

16. Country Level Medical Cart Market Analysis and Forecast 2022 & 2032

17. Market Structure Analysis

18. Competition Analysis

19. Assumptions and Acronyms Used

20. Research Methodology

List of Tables

List of Figures